Call Us Today! (732) 701-7807|info@ozmosi.com
FacebookTwitterLinkedIn

Keeping up with the Pharmaceutical Industry in Asia

2019-07-08T13:19:44+00:00

Keeping up with pharmaceutical landscape around the world, especially in Asia, is essential in today’s market. Here are some of the biggest news stories emerging from Asian countries that are making big strides in drug development. China: Recently, China has been quickly advancing in the process of approving of new drugs. This is in accordance to the new drug registration procedure under the Chinese FDA(CFDA). This new process is helping China to beat other countries, including the US, in the process of bringing drugs to market. For example, China was able to grant Astrazeneca and FribroGen approval for the drug [...]

Keeping up with the Pharmaceutical Industry in Asia2019-07-08T13:19:44+00:00

The Clinical Trial Powershift

2018-10-05T13:47:50+00:00

Pharmaceutical companies are being pushed aside when it comes to who is driving clinical outcomes. Despite the growing number of industry trials year over year, the pharmaceutical industry is taking a back seat to the even faster growing hospital groups and universities in the same space.  Looking back to the year 2000, 8 out of the top 10 clinical trial sponsors were large pharmaceutical companies.  Historically, over the same time period, pharma companies accounted for more than 30% of all clinical trials. Today, not a single pharmaceutical company rises to the level of top 10 clinical trial sponsors, and they account [...]

The Clinical Trial Powershift2018-10-05T13:47:50+00:00

New Faces in Big Pharma & the Rise of the Billion Dollar Deal

2017-07-18T19:33:29+00:00

M&A mania is here. Unprecedented deal values for mergers and acquisitions dominated in 2014.  Worldwide M&A was up 47% since 2013 with 95 deals valued greater than $5 billion, as reported by Reuters. Most deals were transacted in the energy, media/entertainment and healthcare sectors. If history is a guide, the cyclical nature of mergers and acquisitions will continue, and healthcare is no exception. Healthcare deals reach a new high.  Is it supply and demand? Deal values more than tripled last year in the healthcare sector, with the average deal at $1.4 billion. Deals in the healthcare industry are getting pricier, driven [...]

New Faces in Big Pharma & the Rise of the Billion Dollar Deal2017-07-18T19:33:29+00:00
Go to Top